Dr Paul Mulholland

Professional statement

Dr Paul Mulholland is a highly experienced consultant medical oncologist based in London. He exclusively treats brain cancer, specialising in brain tumours, metastasis, neuroendocrine tumours, immunotherapy and clinical trials.
 
He serves as a consultant at University College Hospital, the National Hospital for Neurology and Neurosurgery (part of UCLH), and Mount Vernon Cancer Centre. Additionally, he chairs the HCA Cancer Care brain and CNS tumour board.
 
Dr. Mulholland holds the position of honorary senior lecturer at University College London and serves as a training programme director. His doctoral research at the Cancer Research UK London Research Institute focused on genomic profiling in brain cancer, laying the foundation for his work on biomarkers and therapy targets in this field. He currently oversees a clinical trial portfolio of novel agents in brain cancer at UCLH and on a national scale.
 
Additionally, he holds the role of the clinical lead within Datrix, a European Consortium focused on advancing next-generation targeted hyperthermic cancer treatment for glioblastoma through multidisciplinary collaboration.